Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma × cabazitaxel × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 48 Neoplasm Metastasis 10 Neoplasms 8 Recurrence 7 Prostate Cancer Metastatic 6 Breast Neoplasms 5 Carcinoma, Transitional Cell 4 Stomach Neoplasms 3 Neoplastic Cells, Circulating 3 Metastatic Castration-resistant Prostate Cancer 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms, Castration-Resistant 2 Ovarian Neoplasms 2 Glioblastoma 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Thrombocytosis 1 Solid Cancer 1 Small Cell Lung Carcinoma 1 Prostate Cancer, Hereditary, 7 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Cisplatin 46 Carboplatin 43 pembrolizumab 39 Paclitaxel 38 Gemcitabine 27 Radiotherapy 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 18 Radiotherapy, Intensity-Modulated 17 Docetaxel 17 Specimen Handling 15 Nivolumab 15 Cetuximab 15 Cyclophosphamide 14 durvalumab 13 Fluorouracil 13 130-nm albumin-bound paclitaxel 10 Platinum 9 Bevacizumab 9 osimertinib 8 Sunitinib 8 Sorafenib 8 Radiation 8 Oxaliplatin 8 Irinotecan 8 Everolimus 8 Capecitabine 8 1,2-diaminocyclohexaneplatinum II citrate 8 Ipilimumab 7 Drug Therapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02202772 2025-02-24

CGC

Columbia University

Phase 1/2 Active not recruiting

Carcinoma, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡